Market Cap

$26.5M

Volume

349.2K

Cash and Equivalents

$1.8M

EBITDA

-$13.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

N/A

Profit Margin

N/A

52 Week High

$1.32

52 Week Low

$0.26

Dividend

N/A

Price / Book Value

-20.56

Price / Earnings

-1.44

Price / Tangible Book Value

-20.56

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$13.7M

Return on Equity

387.55%

Return on Assets

-118.19

Cash and Short Term Investments

$1.8M

Debt

N/A

Equity

-$1.3M

Revenue

N/A

Unlevered FCF

-$8.2M

Sector

Pharmaceuticals

Category

N/A